Concentra Group Holdings Parent, Inc. announced its financial results for the first quarter ended March 31, 2025. Revenue increased 7.1% to $500.8 million, compared to $467.6 million in the prior-year quarter. Income from operations grew 6.4% to $80.3 million, while net income decreased to $40.6 million, or $0.30 per basic and diluted share, primarily due to higher interest expense from the IPO recapitalization.
Adjusted EBITDA increased 6.8% to $102.7 million. The company provided updates on its acquisition strategy, confirming the Nova Medical Centers acquisition closed on March 1, 2025, for $265 million, adding 67 centers. Additionally, Concentra signed a definitive agreement on April 18, 2025, to acquire Pivot Onsite Innovations for $55 million, expected to close in Q2 2025, which will add approximately 200 onsite clinics.
Concentra raised its financial guidance for full-year 2025, now expecting revenue between $2,125 million and $2,175 million and Adjusted EBITDA between $420 million and $435 million. The company also declared a cash dividend of $0.0625 per share, payable on May 29, 2025, to stockholders of record as of May 20, 2025. The net leverage ratio as of March 31, 2025, was 3.9x.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.